IncobotulinumtoxinA Injection to Balance Eyebrows and Facial Shapes: A Review with Illustrative Clinical Examples
Abstract
1. Introduction
2. Results
2.1. Search Results and Trial Characteristics
2.2. Eyebrow Shape and Position
2.3. Face and Eyebrow Shapes and Their Importance for Facial Balance
2.4. Gender Differences Regarding Eyebrow Position
2.5. Botulinum Toxin Injections to Change Eyebrows and Improve Facial Balance
2.6. Eyebrow Asymmetry
2.7. Rationale for Rounded Face
2.8. Rationale for Heart-Shaped Face
2.9. Rationale for Long-Shaped Face
3. Discussion
4. Conclusions
5. Materials and Methods
5.1. Search Strategy
5.2. Eligibility Criteria
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| BoNT-A | Botulinum toxin type A |
| IncoBoNT-A | IncobotulinumtoxinA |
| OnaBoNT-A | OnabotulinumtoxinA |
| MPL | Mid-pupillary line |
References
- Richer, V.; Berkowitz, J.; Trindade De Almeida, A. Eyebrow Shape Preference Across Age, Gender, and Self-Reported Ethnic Group. Dermatol. Surg. 2023, 49, 171–176. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bruneau, S.; Foletti, J.M.; Muller, S.; Vercasson, C.; Lauwers, F.; Guyot, L. Does the Eyebrow Sag with Aging? An Anthopometric Study of 95 Caucasians from 20 to 79 Years of Age. Plast. Reconstr. Surg. 2016, 137, 305e–312e. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gunter, J.; Antrobus, S. Aesthetic Analysis of the Eyebrow. Plast. Reconstr. Surg. 1997, 99, 1808–1816. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yalçınkaya, E.; Cingi, C.; Söken, H.; Ulusoy, S.; Muluk, N.B. Aesthetic Analysis of the Ideal Eyebrow Shape and Position. Eur. Arch. Oto-Rhino-Laryngol. 2016, 273, 305–310. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Huang, W.; Rogachefsky, A.S.; Foster, J.A. Browlift with Botulinum Toxin. Dermatol. Surg. 2000, 26, 55–60. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Maas, C.S.; Kim, E.J. Temporal Brow Lift Using Botulinum Toxin A: An Update. Plast. Reconstr. Surg. 2003, 112, 109S–112S. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carruthers, A.; Carruthers, J. Eyebrow Height after Botulinum Toxin Type A to the Glabella. Dermatol. Surg. 2007, 33, S26–S31. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- De Sanctis Pecora, C.; Pinheiro, M.V.B.; Ferreira, K.V.; De Barros Nunes, G.J.; Miot, H.A. The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks. Clin. Cosmet. Investig. Dermatol. 2021, 14, 97–105. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Morikawa, K.; Matsushita, S.; Tomita, A.; Yamanami, H. A Real-Life Illusion of Assimilation in the Human Face: Eye Size Illusion Caused by Eyebrows and Eye Shadow. Front. Hum. Neurosci. 2015, 9, 139. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Solish, N.; Kane, M.A.C.; Biesman, B.S.; Brown, J.; Gallagher, C.J. Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines. Aesthet. Surg. J. 2023, 43, S1–S9. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pecora, C.d.S.; Pateo, B.V.; Nunes, G.J.d.B.; Queiroz, A.E.M.L.; da Silveira, B.R.L.; Van Loghen, J. A Combined Approach Using IncobotulinumtoxinA and CPM-Hyaluronic Acid Injections for the Periorbital Complex Improvement: A Pilot Study. Aesthet. Surg. J. Open Forum 2024, 6, ojae027. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alex, J. Aesthetic Considerations in the Elevation of the Eyebrow. Facial Plast. Surg. 2004, 20, 193–198. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Matsushita, S.; Morikawa, K.; Mitsuzane, S.; Yamanami, H. Eye Shape Illusions Induced by Eyebrow Positions. Perception 2015, 44, 529–540. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Baker, S.B.; Dayan, J.H.; Crane, A.; Kim, S. The Influence of Brow Shape on the Perception of Facial Form and Brow Aesthetics. Plast. Reconstr. Surg. 2007, 119, 2240–2247. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Green, J.B.; Keaney, T.C. Aesthetic Treatment with Botulinum Toxin: Approaches Specific to Men. Dermatol. Surg. 2017, 43, S153–S156. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- McKinney, P.; Mossie, R.D.; Zukowski, M.L. Criteria for the Forehead Lift. Aesthet. Plast. Surg. 1991, 15, 141–147. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ding, A. The Ideal Eyebrow: Lessons Learnt From the Literature. Aesthet. Plast. Surg. 2021, 45, 536–543. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sedgh, J. The Aesthetics of the Upper Face and Brow: Male and Female Differences. Facial Plast. Surg. 2018, 34, 114–118. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carruthers, J.D.A.; Carruthers, J.A. Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin. J. Dermatol. Surg. Oncol. 1992, 18, 17–21. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Muti, G.F.; Basso, M. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA. J. Clin. Aesthet. Dermatol. 2017, 10, 27–29. [Google Scholar] [PubMed]
- Rojo-Sanchis, C.; Montiel-Company, J.M.; Tarazona-Álvarez, B.; Haas-Junior, O.L.; Peiró-Guijarro, M.A.; Paredes-Gallardo, V.; Guijarro-Martínez, R. Non-Surgical Management of the Gingival Smile with Botulinum Toxin A-A Systematic Review and Meta-Analysis. J. Clin. Med. 2023, 12, 1433. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yang, R.; Liu, C.; Liu, W.; Luo, J.; Cheng, S.; Mu, X. Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea. Dermatol. Ther. 2022, 12, 2285–2294. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Luque, A.; Rojas, A.P.; Ortiz-Florez, A.; Perez-Bernal, J. Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea. J. Clin. Aesthet. Dermatol. 2021, 14, 42–45. [Google Scholar] [PubMed]
- Pahwa, R.; Molho, E.; Lew, M.; Dashtipour, K.; Gil, R.A.; Revilla, F.J.; Clinch, T.; Qin, P.; Isaacson, S.H.; Shelepen, K.; et al. Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST Trial. Neurol. Ther. 2025, 14, 1553. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jost, W.H.; Friedman, A.; Michel, O.; Oehlwein, C.; Slawek, J.; Bogucki, A.; Ochudlo, S.; Banach, M.; Pagan, F.; Flatau-Baqué, B.; et al. SIAXI: Placebo-Controlled, Randomized, Double-Blind Study of IncobotulinumtoxinA for Sialorrhea. Neurology 2019, 92, e1982–e1991. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Henning, M.A.S.; Bouazzi, D.; Jemec, G.B.E. Treatment of Hyperhidrosis: An Update. Am. J. Clin. Dermatol. 2022, 23, 635–646. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Nestor, M.S.; Arnold, D.; Fischer, D. The Mechanisms of Action and Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates II. J. Cosmet. Dermatol. 2020, 19, 2785–2804. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kerscher, M.; Roll, S.; Becker, A.; Wigger-Alberti, W. Comparison of the Spread of Three Botulinum Toxin Type A Preparations. Arch. Dermatol. Res. 2012, 304, 155–161. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mariwalla, K.; Shamban, A.; Green, J.B.; Gross, T.M.; Brown, J.; Gallagher, C.J. Clinical Benefits of DaxibotulinumtoxinA for Injection: Beyond Glabellar Line Effacement? Dermatol. Surg. 2024, 50, S18–S23. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Angelo-Khattar, M. A Novel OnabotulinumtoxinA Treatment Technique to Obtain Predictable Outcomes in Eyebrow Position and Shape. Clin. Cosmet. Investig. Dermatol. 2020, 13, 781–787. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Schlager, S.; Kostunov, J.; Henn, D.; Stark, B.G.; Iblher, N. A 3D Morphometrical Evaluation of Brow Position after Standardized Botulinum Toxin a Treatment of the Forehead and Glabella. Aesthet. Surg. J. 2019, 39, 553–564. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cotofana, S.; Solish, N.; Gallagher, C.; Beleznay, K.; Hernandez, C.A.; Bertucci, V. The Anatomy behind Eyebrow Positioning: A Clinical Guide Based on Current Anatomic Concepts. Plast. Reconstr. Surg. 2022, 149, 869–879. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bertucci, V.; Carruthers, J.D.; Sherman, D.D.; Gallagher, C.J.; Brown, J. Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines with Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis. Aesthet. Surg. J. 2023, 43, S19–S31. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bertucci, V.; Green, J.B.; Fezza, J.P.; Brown, J.; Gallagher, C.J.; Solish, N. Impact of Glabellar Injection Technique with DaxibotulinumtoxinA for Injection on Brow Position. Aesthet. Surg. J. 2023, 43, S10–S18. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- de Sanctis Pecora, C.; Pinheiro, M.V.B.; Figueiredo, V.; Guerra, R. Aesthetic ONE21 Technique for Injecting IncobotulinumtoxinA into the Forehead: Initial Experience with 86 Patients. J. Drugs Dermatol. 2021, 20, 31–37. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- de Maio, M.; Swift, A.; Signorini, M.; Fagien, S. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Upper Face. Plast. Reconstr. Surg. 2017, 140, 265e–276e. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bertossi, D.; Cavallini, M.; Cirillo, P.; Piero Fundarò, S.; Quartucci, S.; Sciuto, C.; Tonini, D.; Trocchi, G.; Signorini, M. Italian Consensus Report on the Aesthetic Use of Onabotulinum Toxin A. J. Cosmet. Dermatol. 2018, 17, 719–730. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- El-Khoury, J.S.; Jabbour, S.F.; Awaida, C.J.; Rayess, Y.A.; Kechichian, E.G.; Nasr, M.W. The Impact of Botulinum Toxin on Brow Height and Morphology: A Randomized Controlled Trial. Plast. Reconstr. Surg. 2018, 141, 75–78. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- de Sanctis Pecora, C.; Kerscher, M.; Muniz, M.; Trindade de Almeida, A. Why, When, and How to Treat Dynamic Forehead Lines with Botulinum Toxin Type A. Toxins 2025, 17, 603. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Scève, M. Le Sourcil. Available online: https://www.lelivrescolaire.fr/page/6418346 (accessed on 22 August 2024).
- Fakih-Gomez, N.; Muñoz-Gonzalez, C. Moose Technique: A New Anatomical Perspective Treatment in Botulinum Toxin. J. Cosmet. Dermatol. 2025, 24, e70511. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ahn, B.K.; Kim, Y.S.; Kim, H.J.; Rho, N.K.; Kim, H.S. Consensus Recommendations on the Aesthetic Usage of Botulinum Toxin Type A in Asians. Dermatol. Surg. 2013, 39, 1843–1860. [Google Scholar] [CrossRef] [Scilit] [PubMed]




| Facial Shape | Characteristics | Adequated Eyebrow Position | Warnings in Toxin Injection |
|---|---|---|---|
![]() Oval | This is the ideal facial shape. Balanced proportions, with slightly wider cheekbones than the forehead and a gently rounded chin. | Curved, Sharp Angled, Soft Angled, Rounded or Flat Eyebrow plays no significant role in making the face appearance. | As this face shape is considered ideal and intrinsically balanced, toxin application can be guided by personal preferences. |
![]() Rounded | Soft, curved lines with similar width and length of the face measures. Cheekbones and face width are almost equal, with a rounded jawline. | High Arched, Low/Medium tail, helps elongate the face’s appearance. | Rounded eyebrows can turn that same face into a “beach ball” To make a round face appear oval, one should apply lines that go up the face. The peak is best moved out toward the end of the eyebrow. This lets the lines of the brow go up and down as much as possible. |
![]() Long | Longer length than width measures, with straight cheekbones and a squared jawline. | Flat and relatively lower-posited or soft-angled eyebrows add width to the face’s appearance. | Avoid arched and picked brows, because this will create vertical lines making the face appear even longer. |
![]() Square | Strong jawline and equal width at the forehead, cheeks, and jaw. | Strong angled eyebrows balance with the jawline, harmonizing the face’s appearance | The peak of the brow is most effective when directly above the square of the jaw. |
![]() Heart | Forehead and cheekbones with the same width, a narrower jaw and more angled chin and long straight jaw lines. Longer length than width measures. | A round shape helps by adding curves to soften the face and emphasizes the lovely heart shape | A round eyebrow shape, with the pick in between the lateral limbus and lateral canthus line helps to soften and balance the face. |
| Objective to Be Reached | ![]() Laterally Arched | ![]() Rounded | ![]() Flat | |
| Original Shape | ||||
![]() Laterally arched | Glabella + orbicularis (red, green and blue points) + frontalis (blockage partial of the mid-pupillary line compared to the outer canthus line in the intermediate and superior lines. Inferior limit line—inject only in the facial central line. | Glabella + orbicularis (only lateral points, if necessary) + frontalis (higher dosage laterally compared to the central part in the intermediate and upper lines, injecting the highest dosage in the outer canthus line. Inferior limit line—inject in the mid-pupillary line and outer canthus line, avoid injecting the central points) | ||
![]() Rounded | Glabella + orbicularis (red points) + frontalis (highest dosage in the central part (including mid-pupillary line) lower dosage laterally in the intermediate and superior lines. Inferior limit line—inject in the facial central line and inner canthus line and another point using lower dosage in the mid-pupillary line. | Glabella + orbicularis (only lateral points, if necessary) + frontalis (highest dosage on the mid-pupillary line and outer canthus line in the intermediate and upper lines. Inferior limit line—inject in the mid-pupillary line and outer canthus line. | ||
![]() Flat | Glabella + orbicularis (red points) + frontalis (highest dosage in the central part (including mid-pupillary line) lower dosage laterally in the intermediate and superior lines. Inferior limit line—inject in the facial central line and inner canthus line and another point using lower dosage in the mid-pupillary line. | Glabella + orbicularis (red, green and blue points) + frontalis (highest dosage in the central facial line and inner canthus line, lower dosage laterally in the intermediate and superior lines. Inferior limit line—inject only in the facial central line. | ||
| Muscle Group | Number of Injection Points | Injection Technique * | Dosage |
|---|---|---|---|
| Occipitofrontalis | Customized | Insert 30% of the needle angled upwards. Extend the injection sites laterally along the lateral canthus. | 0.5 to 2 U/point |
| Corrugator supercilii | 2 (origin and tail) * 3rd point (lateral, blending with orbicularis oculi fibers) | Origin: introduce 100% of the needle. Insertion: introduce 30% of the needle. * 3rd point: introduce the needle bevel only. | 4 to 6 U/point. * 3rd point: 0.5 to 2 U |
| Procerus | 1 to 2 | Introduce 50% of the needle directed upwards. | 4 to 8 U |
| Depressor supercilii | 1 | Subdermal injection, directing the needle medially and upwards. | 1 to 2 U |
| Orbicularis oculi | 3 to 8 * MPL point (blending of lateral corrugator with orbicularis oculi fibers) | Insert 30% of the needle superficially, directing the needle away from the eye. * MPL point: introduce the needle bevel only. Care should be taken to avoid injecting into the supro-orbital forâmen. | 4 U/point (lateral radial lines) 2 U/point (inferior line and lateral end of the brow) 0.5 to 2 U (superior lateral orbicularis) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Pecora, C.d.S.; Blessmann-Gurk, B.; Viscomi, B. IncobotulinumtoxinA Injection to Balance Eyebrows and Facial Shapes: A Review with Illustrative Clinical Examples. Toxins 2026, 18, 296. https://doi.org/10.3390/toxins18070296
Pecora CdS, Blessmann-Gurk B, Viscomi B. IncobotulinumtoxinA Injection to Balance Eyebrows and Facial Shapes: A Review with Illustrative Clinical Examples. Toxins. 2026; 18(7):296. https://doi.org/10.3390/toxins18070296
Chicago/Turabian StylePecora, Carla de Sanctis, Birgit Blessmann-Gurk, and Bianca Viscomi. 2026. "IncobotulinumtoxinA Injection to Balance Eyebrows and Facial Shapes: A Review with Illustrative Clinical Examples" Toxins 18, no. 7: 296. https://doi.org/10.3390/toxins18070296
APA StylePecora, C. d. S., Blessmann-Gurk, B., & Viscomi, B. (2026). IncobotulinumtoxinA Injection to Balance Eyebrows and Facial Shapes: A Review with Illustrative Clinical Examples. Toxins, 18(7), 296. https://doi.org/10.3390/toxins18070296












